Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
28,417,218
-
Total 13F shares
-
2,969,361
-
Share change
-
-381,280
-
Total reported value
-
$38,750,000
-
Put/Call ratio
-
11%
-
Price per share
-
$13.05
-
Number of holders
-
41
-
Value change
-
-$3,308,266
-
Number of buys
-
21
-
Number of sells
-
38
Institutional Holders of ClearPoint Neuro, Inc. - Common Stock, $0.01 par value (CLPT) as of Q2 2022
As of 30 Jun 2022,
ClearPoint Neuro, Inc. - Common Stock, $0.01 par value (CLPT) was held by
41 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,969,361 shares.
The largest 10 holders included
VANGUARD GROUP INC, BROWN ADVISORY INC, MILLENNIUM MANAGEMENT LLC, Taylor Frigon Capital Management LLC, GEODE CAPITAL MANAGEMENT, LLC, CM Management, LLC, PARSONS CAPITAL MANAGEMENT INC/RI, ESSEX INVESTMENT MANAGEMENT CO LLC, Cahill Wealth Management, LLC, and Ergoteles LLC.
This page lists
42
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.